PHARMACY

APP Pharmaceuticals gets FDA OK for myxedema coma treatment

BY Allison Cerra

SCHAUMBURG, Ill. — APP Pharmaceuticals has received regulatory approval for the treatment of a complication related to hypothyroidism.

APP said that its levothyroxine sodium for injection will be marketed in single-dose 100-mcg, 200-mcg and 500-mcg vials. The drug is designed to treat myxedema coma, a life-threatening complication of hypothyroidism.

“APP worked closely with the FDA to secure approval of levothyroxine sodium for injection because of the expressed medical need for this drug,” APP Pharmaceuticals president and CEO John Ducker said. “We will continue to collaborate with the FDA to gain approval of established and much-needed drugs that maintain the highest standards of quality, safety and efficacy.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Collis succeeds Yost as CEO of AmerisourceBergen

BY Michael Johnsen

VALLEY FORGE, Pa. — David Yost officially handed the reins of AmerisourceBergen to Steven Collis, who was named president and CEO on Friday, as Yost prepares for retirement.

"On behalf of our entire company, I thank Dave for his 37 years of extraordinary service to AmerisourceBergen, and for his gracious support during the leadership transition," Collis stated. "I believe with our momentum, our position in growing markets, our talented and seasoned management team, and our dedication to efficiency and innovative customer service, we will continue to drive success by growing our business and providing value to our customers, suppliers, shareholders and our associates."

Collis previously served as president and COO, responsible for all AmerisourceBergen business units, including AmerisourceBergen Drug Corp., AmerisourceBergen Specialty Group, AmerisourceBergen Consulting Services and AmerisourceBergen Packaging Group. Before being promoted to that position in November 2010, Collis was AmerisourceBergen EVP and president of ABDC, the company’s largest subsidiary with revenues of more than $60 billion.

keyboard_arrow_downCOMMENTS

Leave a Reply

D.DEMII says:
Nov-19-2012 02:23 am

Fully agree with your points here. All the posts are fully informative and having very good themes. I love to visit your blog again and again its really increase my knowledge. Thanks for the awesome post. Pakistan Fashion Events

N.OYOLA says:
Jul-05-2011 12:16 pm

Congratulations! Nilda L. Oyola National Sales and Marketing Manager Majestic Drug Co., Inc.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

McKesson to amplify independent pharmacies’ healthcare delivery role

BY Michael Johnsen

SAN FRANCISCO — McKesson sparked its McKesson IdeaShare Conference at the Moscone Convention Center here from June 29 through July 2 with a number of programs designed to bolster the competitiveness and profitability among independent pharmacies.

“Today’s evolving healthcare landscape is providing more opportunities than ever before for independent pharmacies to elevate their role in healthcare delivery, more tightly align with other healthcare providers and increase their connection with patients,” said Brian Tyler, McKesson U.S. pharmaceutical president. “McKesson ideaShare is designed to inspire and support independent pharmacies as they pursue and achieve new levels of clinical and business success.”

McKesson used the conference as a launch pad for its Physician Outreach Program, a solution that enables independent pharmacies to identify and better partner with physicians in their area. The program will help pharmacists target high-volume prescribers to help promote the personalized services and clinical expertise they offer.

McKesson also enabled its consumer outreach with a Mobile Messaging program. As more patients are connecting to healthcare providers in new and different ways, McKesson’s new suite of messaging services will allow independent pharmacists to send automated medication reminders, pick-up notifications and auto-refill messages via text, email or automated phone messages directly to their patients’ mobile devices.

McKesson also showcased its new private-label brand program, announcing the first round of the new store brands will reach shelves in October and subsequent category launches in the months to follow.

To help maximize reimbursements for services rendered, McKesson introduced its McKesson Reimbursement Solutions, a suite of reimbursement solutions to help pharmacists capture maximum reimbursement for the prescriptions they dispense. The suite included tailored solutions to meet the needs for all independent pharmacies, whether they’re part of the Health Mart franchise, McKesson’s AccessHealth managed care network or unaffiliated with either.

McKesson also is helping its independent pharmacy customers provide flu vaccines to consumers now that pharmacists can administer those inoculations in all 50 states.

Additionally, McKesson announced that the Health Mart Healthy Living Tour kicked off its 2011 tour. The Living Tour features a mobile screening unit that will travel across the country to raise diabetes awareness by administering free health screenings and providing diabetes education. The tour will visit 20 states across the United States through November 2011.

Looking forward, McKesson announced the creation of an online community for Health Mart pharmacists to go live in the fall. Participating pharmacists will be able to gain easy access to McKesson Connect Community through McKesson Connect, McKesson’s online pharmaceutical ordering portal. McKesson Connect Community will be rolled out to additional McKesson independent pharmacy customers throughout the year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?